Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Day

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
BMC Cancer|July 22, 2008
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseGary Beale, Dipankar Chattopadhyay, Joe Gray, et al.
Cureus|July 7, 2023
Arterio-Ureteral Fistula: A Rare Elusive Cause of Significant HematuriaMuhammad Waqar, Suresh-Jay Mathias, Vinodh Murali, et al.
Pediatric Transplantation|August 11, 2020
Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary diseaseRyan T Fischer, J Christopher Day, Heather Wasserkrug, et al.
Journal of Pharmaceutical Sciences|October 21, 2021
ICH Q3D Drug Product Elemental Risk Assessment: The Use of An Elemental Impurities Excipients DatabaseSusana Torres, Ruth Boetzel, Enid Gatimu, et al.
Pathology|October 31, 2015
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2Admire Matsika, Bhuvana Srinivasan, Christopher Day, et al.
Haematologica|July 18, 2024
Risk of infections in multiple myeloma. A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma RegistryCecilie Hveding Blimark, Kristina Carlson, Christopher Day, et al.
Journal of Hepatology|January 24, 2002
Transplantation for alcoholic liver diseaseJames Neuberger, Karl-Heinz Schulz, Christopher Day, et al.
Annals of Hematology|January 23, 2025
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish myeloma registryGunnar Larfors, Kristina Carlson, Christopher Day, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|June 26, 2026
When everything is violence, nothing is violence: Response to Koot et al. (2020)Fergus O'Leary Simpson, Lorenzo Pellegrini, Olajide Akinleye-Martins, et al.
Gut|August 3, 2010
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver diseaseJulie Parkes, Paul Roderick, Scott Harris, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 22, 2008
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseGary Beale, Dipankar Chattopadhyay, Joe Gray, et al.
Cureus|July 7, 2023
Arterio-Ureteral Fistula: A Rare Elusive Cause of Significant HematuriaMuhammad Waqar, Suresh-Jay Mathias, Vinodh Murali, et al.
Pediatric Transplantation|August 11, 2020
Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary diseaseRyan T Fischer, J Christopher Day, Heather Wasserkrug, et al.
Journal of Pharmaceutical Sciences|October 21, 2021
ICH Q3D Drug Product Elemental Risk Assessment: The Use of An Elemental Impurities Excipients DatabaseSusana Torres, Ruth Boetzel, Enid Gatimu, et al.
Pathology|October 31, 2015
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2Admire Matsika, Bhuvana Srinivasan, Christopher Day, et al.
Haematologica|July 18, 2024
Risk of infections in multiple myeloma. A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma RegistryCecilie Hveding Blimark, Kristina Carlson, Christopher Day, et al.
Journal of Hepatology|January 24, 2002
Transplantation for alcoholic liver diseaseJames Neuberger, Karl-Heinz Schulz, Christopher Day, et al.
Annals of Hematology|January 23, 2025
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish myeloma registryGunnar Larfors, Kristina Carlson, Christopher Day, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|June 26, 2026
When everything is violence, nothing is violence: Response to Koot et al. (2020)Fergus O'Leary Simpson, Lorenzo Pellegrini, Olajide Akinleye-Martins, et al.
Gut|August 3, 2010
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver diseaseJulie Parkes, Paul Roderick, Scott Harris, et al.
Pageof 5